{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:23:12Z","timestamp":1790720592656,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.bulcan.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T15:00:51Z","timestamp":1510844451000},"page":"929-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Appel \u00e0 une meilleure utilisation du midazolam en fin de vie\u00a0: \u00e9valuation des pratiques professionnelles dans un service d\u2019oncologie m\u00e9dicale"],"prefix":"10.1016","volume":"104","author":[{"given":"Aur\u00e9lie","family":"Beneton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Vallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Brosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Poenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pacaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Morisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2017.10.003_bib0005","unstructured":"A. Claeys JL. Rapport de pr\u00e9sentation et texte de la proposition de L de MM. Alain Claeys et Jean Leonetti cr\u00e9ant de nouveaux droits en faveurs des malades et des personnes en fin de vie. http:\/\/www.elysee.fr\/assets\/Uploads\/Rapport-et-proposition-de-loi-creant-de-nouveaux-droits-en-faveur-des-malades-et-des-personnes-en-fin-de-vie.pdf [Dernier acc\u00e8s le 07\/07\/17]."},{"key":"10.1016\/j.bulcan.2017.10.003_bib0010","series-title":"S\u00e9dation pour d\u00e9tresse en phase terminale et dans des situations sp\u00e9cifiques et complexes\u00a0: recommandations chez l\u2019adulte et sp\u00e9cificit\u00e9s au domicile et en g\u00e9riatrie","author":"SFAP","year":"2010"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0015","unstructured":"SFAP. S\u00e9dation pour d\u00e9tresse en phase terminale et dans des situations sp\u00e9cifiques et complexes n.d."},{"key":"10.1016\/j.bulcan.2017.10.003_bib0020","first-page":"71","article-title":"La s\u00e9dation pour d\u00e9tresse chez l\u2019adulte dans des situations sp\u00e9cifiques et complexes","volume":"9","author":"Aubry","year":"2010","journal-title":"Med Palliat"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpainsymman.2007.01.005","article-title":"A national guideline for palliative sedation in the Netherlands","volume":"34","author":"Verkerk","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jpainsymman.2007.10.004","article-title":"Palliative sedation: a review of the research literature","volume":"36","author":"Claessens","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jpm.2006.0139","article-title":"Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards","volume":"10","author":"De Graeff","year":"2007","journal-title":"J Palliat Med"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0040","unstructured":"S\u00e9dation - corig\u00e9 vb - sedation-phase-terminale.pdf n.d. http:\/\/www.sfap.org\/system\/files\/sedation-phase-terminale.pdf. (accessed February 3, 2017)."},{"key":"10.1016\/j.bulcan.2017.10.003_bib0045","first-page":"1","volume":"2002","year":"2005"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0050","unstructured":"J. Girardier, JL. Beal VA. 43\u00a0Les situations extremes en soins palliatifs n.d."},{"key":"10.1016\/j.bulcan.2017.10.003_bib0055","first-page":"10","article-title":"JORF no\u00a095\u00a0du 23\u00a0avril 2005\u00a0page 7089\u00a0texte no\u00a01. LOI no\u00a02005-370\u00a0du 22\u00a0avril 2005\u00a0relative aux droits des malades et \u00e0 la fin de vie","year":"2005","journal-title":"JORF"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/104990910001700313","article-title":"42\u00a0terminal sedation for existential distress","volume":"17","author":"Morita","year":"2000","journal-title":"Am J Hosp Palliat Care Palliat Med"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0065","series-title":"Recommandations de bonne pratique\u00a0: douleur rebelle en situation palliative avanc\u00e9e chez l\u2019adulte","author":"AFSSAPS","year":"2010"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0070","first-page":"255","article-title":"Soins palliatifs\u00a0: sp\u00e9cificit\u00e9 d\u2019utilisation des m\u00e9dicaments courants hors antalgiques","volume":"90","author":"Afssaps","year":"2003","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1684\/bdc.2013.1795","article-title":"Use of midazolam in hospitalized patients: analysis of medical practice","volume":"100","author":"Giroud","year":"2013","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0080","first-page":"CD010206","article-title":"Palliative pharmacological sedation for terminally ill adults","volume":"1","author":"Beller","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0973-1075.110236","article-title":"Palliative sedation in advanced cancer patients: does it shorten survival time? A systematic review","volume":"19","author":"Barathi","year":"2013","journal-title":"In J Palliat Care"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1470-2045(03)01079-9","article-title":"The use of opioids and sedatives at the end of life personal view","volume":"4","author":"Sykes","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0095","first-page":"1","article-title":"Palliative sedation for cancer patients included in a home care program: a retrospective study","author":"Calvo-Espinos","year":"2014","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1757-1626-2-136","article-title":"Patient and\/or family controlled palliative sedation with midazolam for intractable symptom control: a case series","volume":"2","author":"Aretha","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpainsymman.2008.04.020","article-title":"Controlled sedation for refractory symptoms in dying patients","volume":"37","author":"Mercadante","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2017.10.003_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-684X-2-2","article-title":"Sedation in palliative care, a critical analysis of seven years experience","volume":"2","author":"Muller-Busch","year":"2003","journal-title":"BMC Palliat Care"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T06:52:44Z","timestamp":1570344764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455117302679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0007455117302679"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.10.003","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appel \u00e0 une meilleure utilisation du midazolam en fin de vie\u00a0: \u00e9valuation des pratiques professionnelles dans un service d\u2019oncologie m\u00e9dicale","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}